Iraq's oil production in September was below its OPEC+ quota, producing 3.94 million barrels per day, as the country aims to improve compliance with its production targets.
In September 2024, Iraq's oil production fell to 3.94 million barrels per day (bpd), falling short of its OPEC+ quota of approximately 4 million bpd. This development was confirmed by an Iraqi official, who attributed the shortfall to decreased exports, reduced domestic consumption, and a decline in output from the Kurdistan Region. The official's statement contradicts a Reuters survey published on October 3, which reported that Iraq had exceeded its quota by 90,000 bpd in September.
The discrepancy between the official figures and the Reuters survey highlights ongoing challenges in accurately tracking oil production levels. Iraq's efforts to adhere to its OPEC+ commitments come amid broader discussions within the organization about compliance with production quotas. Iraq, along with Kazakhstan, has pledged to make compensation cuts to offset previous overproduction.
The issue of quota compliance remains a significant focus for OPEC+, particularly concerning Iraq and Kazakhstan. Both countries have committed to reducing their production by 123,000 bpd in September and further cuts in subsequent months to compensate for past overproduction. This commitment was reiterated during a recent meeting of OPEC+ ministers, where Iraq, Kazakhstan, and Russia confirmed their adherence to the agreed cuts.
Iraq's production strategy includes plans to reduce output to between 3.85 million and 3.9 million bpd as part of its compensation efforts. The country's adherence to these targets is crucial for maintaining stability within the OPEC+ framework and ensuring balanced global oil markets.
The ongoing adjustments in Iraq's oil production underscore the complexities of managing national output in alignment with international agreements, particularly in a region with diverse geopolitical and economic pressures.
Party City, a leading retailer in the party supplies industry, has announced the closure of all its stores following financial struggles and a recent bankruptcy filing. The company, which has been in business for nearly 40 years, cited inflation and decreased consumer spending as key factors in its decision to wind down operations.
Honda and Nissan are reportedly in talks for a potential merger to address challenges in the automotive industry, including competition from electric vehicle manufacturers.
Google proposes to modify its search engine agreements to address US antitrust concerns, while planning to appeal the ruling.
The US FDA has approved Novo Nordisk's Alhemo, a groundbreaking treatment for hemophilia A and B with inhibitors, marking a significant advancement in hemophilia care.
The US FDA has declined to approve Lexicon Pharmaceuticals' Zynquista as an add-on treatment for type 1 diabetes and chronic kidney disease, prompting the company to shift focus to other drug candidates.
Sarepta Therapeutics Inc. has secured a $115.2 million verdict against Nippon Shinyaku Co. Ltd. for patent infringement related to its Duchenne muscular dystrophy drug, Vyondys 53.
A US jury remains deadlocked in the high-stakes trial between Arm Holdings and Qualcomm over a licensing dispute involving Nuvia's chip designs, with deliberations ongoing.
Netflix has acquired the exclusive U.S. broadcasting rights for the FIFA Women's World Cup in 2027 and 2031, marking a significant move into live sports for the streaming giant.
Carnival Corporation & plc has reported record earnings for 2024, surpassing guidance and setting a positive outlook for 2025 with expected earnings growth and strong booking volumes.
United States Steel Corporation's stock has taken a hit following a weaker-than-expected fourth-quarter outlook, with projected losses and challenges in the steel market.